1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Tests Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Blood Tests
1.2.3 Urine Drug Tests
1.2.4 Hair Drug Testing
1.2.5 Alcohol Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Tests Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Individuals
1.3.3 Companies
1.3.4 Government
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Tests Services Market Perspective (2017-2028)
2.2 Drug Tests Services Growth Trends by Region
2.2.1 Drug Tests Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drug Tests Services Historic Market Size by Region (2017-2022)
2.2.3 Drug Tests Services Forecasted Market Size by Region (2023-2028)
2.3 Drug Tests Services Market Dynamics
2.3.1 Drug Tests Services Industry Trends
2.3.2 Drug Tests Services Market Drivers
2.3.3 Drug Tests Services Market Challenges
2.3.4 Drug Tests Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Tests Services Players by Revenue
3.1.1 Global Top Drug Tests Services Players by Revenue (2017-2022)
3.1.2 Global Drug Tests Services Revenue Market Share by Players (2017-2022)
3.2 Global Drug Tests Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Tests Services Revenue
3.4 Global Drug Tests Services Market Concentration Ratio
3.4.1 Global Drug Tests Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Tests Services Revenue in 2021
3.5 Drug Tests Services Key Players Head office and Area Served
3.6 Key Players Drug Tests Services Product Solution and Service
3.7 Date of Enter into Drug Tests Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Tests Services Breakdown Data by Type
4.1 Global Drug Tests Services Historic Market Size by Type (2017-2022)
4.2 Global Drug Tests Services Forecasted Market Size by Type (2023-2028)
5 Drug Tests Services Breakdown Data by Application
5.1 Global Drug Tests Services Historic Market Size by Application (2017-2022)
5.2 Global Drug Tests Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drug Tests Services Market Size (2017-2028)
6.2 North America Drug Tests Services Market Size by Country (2017-2022)
6.3 North America Drug Tests Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Drug Tests Services Market Size (2017-2028)
7.2 Europe Drug Tests Services Market Size by Country (2017-2022)
7.3 Europe Drug Tests Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Tests Services Market Size (2017-2028)
8.2 Asia-Pacific Drug Tests Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Drug Tests Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Drug Tests Services Market Size (2017-2028)
9.2 Latin America Drug Tests Services Market Size by Country (2017-2022)
9.3 Latin America Drug Tests Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Tests Services Market Size (2017-2028)
10.2 Middle East & Africa Drug Tests Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Drug Tests Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Health Street
11.1.1 Health Street Company Detail
11.1.2 Health Street Business Overview
11.1.3 Health Street Drug Tests Services Introduction
11.1.4 Health Street Revenue in Drug Tests Services Business (2017-2022)
11.1.5 Health Street Recent Development
11.2 First Advantage
11.2.1 First Advantage Company Detail
11.2.2 First Advantage Business Overview
11.2.3 First Advantage Drug Tests Services Introduction
11.2.4 First Advantage Revenue in Drug Tests Services Business (2017-2022)
11.2.5 First Advantage Recent Development
11.3 Drug Testing Services Auckland Ltd.
11.3.1 Drug Testing Services Auckland Ltd. Company Detail
11.3.2 Drug Testing Services Auckland Ltd. Business Overview
11.3.3 Drug Testing Services Auckland Ltd. Drug Tests Services Introduction
11.3.4 Drug Testing Services Auckland Ltd. Revenue in Drug Tests Services Business (2017-2022)
11.3.5 Drug Testing Services Auckland Ltd. Recent Development
11.4 US Drug Test Centers
11.4.1 US Drug Test Centers Company Detail
11.4.2 US Drug Test Centers Business Overview
11.4.3 US Drug Test Centers Drug Tests Services Introduction
11.4.4 US Drug Test Centers Revenue in Drug Tests Services Business (2017-2022)
11.4.5 US Drug Test Centers Recent Development
11.5 U.S. Mobile Health Exams
11.5.1 U.S. Mobile Health Exams Company Detail
11.5.2 U.S. Mobile Health Exams Business Overview
11.5.3 U.S. Mobile Health Exams Drug Tests Services Introduction
11.5.4 U.S. Mobile Health Exams Revenue in Drug Tests Services Business (2017-2022)
11.5.5 U.S. Mobile Health Exams Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Detail
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Drug Tests Services Introduction
11.6.4 Eurofins Scientific Revenue in Drug Tests Services Business (2017-2022)
11.6.5 Eurofins Scientific Recent Development
11.7 Sterling
11.7.1 Sterling Company Detail
11.7.2 Sterling Business Overview
11.7.3 Sterling Drug Tests Services Introduction
11.7.4 Sterling Revenue in Drug Tests Services Business (2017-2022)
11.7.5 Sterling Recent Development
11.8 EBI
11.8.1 EBI Company Detail
11.8.2 EBI Business Overview
11.8.3 EBI Drug Tests Services Introduction
11.8.4 EBI Revenue in Drug Tests Services Business (2017-2022)
11.8.5 EBI Recent Development
11.9 National Drug Screening
11.9.1 National Drug Screening Company Detail
11.9.2 National Drug Screening Business Overview
11.9.3 National Drug Screening Drug Tests Services Introduction
11.9.4 National Drug Screening Revenue in Drug Tests Services Business (2017-2022)
11.9.5 National Drug Screening Recent Development
11.10 Meridian HealthCare
11.10.1 Meridian HealthCare Company Detail
11.10.2 Meridian HealthCare Business Overview
11.10.3 Meridian HealthCare Drug Tests Services Introduction
11.10.4 Meridian HealthCare Revenue in Drug Tests Services Business (2017-2022)
11.10.5 Meridian HealthCare Recent Development
11.11 Clinical Labs
11.11.1 Clinical Labs Company Detail
11.11.2 Clinical Labs Business Overview
11.11.3 Clinical Labs Drug Tests Services Introduction
11.11.4 Clinical Labs Revenue in Drug Tests Services Business (2017-2022)
11.11.5 Clinical Labs Recent Development
11.12 Randox Testing Services
11.12.1 Randox Testing Services Company Detail
11.12.2 Randox Testing Services Business Overview
11.12.3 Randox Testing Services Drug Tests Services Introduction
11.12.4 Randox Testing Services Revenue in Drug Tests Services Business (2017-2022)
11.12.5 Randox Testing Services Recent Development
11.13 Cansford Labs
11.13.1 Cansford Labs Company Detail
11.13.2 Cansford Labs Business Overview
11.13.3 Cansford Labs Drug Tests Services Introduction
11.13.4 Cansford Labs Revenue in Drug Tests Services Business (2017-2022)
11.13.5 Cansford Labs Recent Development
11.14 DISA
11.14.1 DISA Company Detail
11.14.2 DISA Business Overview
11.14.3 DISA Drug Tests Services Introduction
11.14.4 DISA Revenue in Drug Tests Services Business (2017-2022)
11.14.5 DISA Recent Development
11.15 Dynacare
11.15.1 Dynacare Company Detail
11.15.2 Dynacare Business Overview
11.15.3 Dynacare Drug Tests Services Introduction
11.15.4 Dynacare Revenue in Drug Tests Services Business (2017-2022)
11.15.5 Dynacare Recent Development
11.16 Lake Region Healthcare
11.16.1 Lake Region Healthcare Company Detail
11.16.2 Lake Region Healthcare Business Overview
11.16.3 Lake Region Healthcare Drug Tests Services Introduction
11.16.4 Lake Region Healthcare Revenue in Drug Tests Services Business (2017-2022)
11.16.5 Lake Region Healthcare Recent Development
11.17 Cisive
11.17.1 Cisive Company Detail
11.17.2 Cisive Business Overview
11.17.3 Cisive Drug Tests Services Introduction
11.17.4 Cisive Revenue in Drug Tests Services Business (2017-2022)
11.17.5 Cisive Recent Development
11.18 Floyd Corporate Health
11.18.1 Floyd Corporate Health Company Detail
11.18.2 Floyd Corporate Health Business Overview
11.18.3 Floyd Corporate Health Drug Tests Services Introduction
11.18.4 Floyd Corporate Health Revenue in Drug Tests Services Business (2017-2022)
11.18.5 Floyd Corporate Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
